53 related articles for article (PubMed ID: 27552937)
1. [Antidepressant guidelines poorly adhered to in young people].
de Vries YA; de Jonge P; Kalverdijk L; Bos HJ; Schuiling-Veninga CC; Hak E
Ned Tijdschr Geneeskd; 2016; 160():D627. PubMed ID: 27552937
[TBL] [Abstract][Full Text] [Related]
2. Poor guideline adherence in the initiation of antidepressant treatment in children and adolescents in the Netherlands: choice of antidepressant and dose.
de Vries YA; de Jonge P; Kalverdijk L; Bos JH; Schuiling-Veninga CC; Hak E
Eur Child Adolesc Psychiatry; 2016 Nov; 25(11):1161-1170. PubMed ID: 26988978
[TBL] [Abstract][Full Text] [Related]
3. Clinical practice guidelines for depression in young people.
Jureidini JN; Tonkin AL
Med J Aust; 2003 Mar; 178(6):300; author reply 300-2. PubMed ID: 12633493
[No Abstract] [Full Text] [Related]
4. Prescription Pattern of Antidepressants for Children and Adolescents in Korea Based on Nationwide Data.
Chon MW; Lee J; Chung S; Kim Y; Kim HW
J Korean Med Sci; 2017 Oct; 32(10):1694-1701. PubMed ID: 28875616
[TBL] [Abstract][Full Text] [Related]
5. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
6. Outpatient treatment in German adolescents with depression: an analysis of nationwide health insurance data.
Hoffmann F; Glaeske G; Petermann F; Bachmann CJ
Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):972-9. PubMed ID: 22639197
[TBL] [Abstract][Full Text] [Related]
7. A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine.
Nakonezny PA; Hughes CW; Mayes TL; Sternweis-Yang KH; Kennard BD; Byerly MJ; Emslie GJ
J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):431-9. PubMed ID: 20973714
[TBL] [Abstract][Full Text] [Related]
8. Placental passage of antidepressant medications.
Hendrick V; Stowe ZN; Altshuler LL; Hwang S; Lee E; Haynes D
Am J Psychiatry; 2003 May; 160(5):993-6. PubMed ID: 12727706
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization.
Sclar DA; Robison LM; Skaer TL; Galin RS; Legg RF; Nemec NL; Hughes TE; Buesching DP; Morgan M
J Int Med Res; 1995; 23(6):395-412. PubMed ID: 8746607
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
[TBL] [Abstract][Full Text] [Related]
11. [Antidepressants and tamoxifen: an unrecognized interaction].
Moulis M; Khouri C; Mallaret M
Therapie; 2014; 69(2):178-9. PubMed ID: 24926638
[TBL] [Abstract][Full Text] [Related]
12. [Pattern of usage of new antidepressants in clinical practice].
Montejo AL; Gilaberte I; Fombellida C; Hylan TR; Sacristán JA
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(2):75-81. PubMed ID: 9595820
[TBL] [Abstract][Full Text] [Related]
13. Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.
Alacqua M; Trifirò G; Arcoraci V; Germanò E; Magazù A; Calarese T; Di Vita G; Gagliano C; Spina E
Pharm World Sci; 2008 Jan; 30(1):44-50. PubMed ID: 17588130
[TBL] [Abstract][Full Text] [Related]
14. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
Nau DP; Chao J; Aikens JE
Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects.
Geretsegger C; Böhmer F; Ludwig M
Int Clin Psychopharmacol; 1994; 9(1):25-9. PubMed ID: 8195578
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period.
Kreider MS; Bushnell WD; Oakes R; Wheadon DE
J Clin Psychiatry; 1995 Apr; 56(4):142-5. PubMed ID: 7713852
[TBL] [Abstract][Full Text] [Related]
17. Is metabolic dysregulation associated with antidepressant response in depressed women in climacteric treated with individualized homeopathic medicines or fluoxetine? The HOMDEP-MENOP Study.
Macías-Cortés ED; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J
Homeopathy; 2017 Feb; 106(1):3-10. PubMed ID: 28325221
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.
Mines D; Hill D; Yu H; Novelli L
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):367-72. PubMed ID: 15883980
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine.
Gassó P; Rodríguez N; Blázquez A; Monteagudo A; Boloc D; Plana MT; Lafuente A; Lázaro L; Arnaiz JA; Mas S
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():28-34. PubMed ID: 28025020
[TBL] [Abstract][Full Text] [Related]
20. Induction of mania in depression by paroxetine.
Morishita S; Arita S
Hum Psychopharmacol; 2003 Oct; 18(7):565-8. PubMed ID: 14533140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
